COVID-19 HEALTH IMPROVEMENT PLAN.PDF

DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Award
Award# 1 NH75OT000011-01-00
Centers for Disease Control and Prevention
FAIN# NH75OT000011
Federal Award Date: 05/26/2021
Recipient Information Federal Award Information
1. Recipient Name 11. Award Number
1 NH75OT000011-01-00
MARICOPA, COUNTY OF 12. Unique Federal Award Identification Number (FAIN)
4041 N Central Ave Ste 1400 NH75OT000011
Community Health Services 13. Statutory Authority
PHOENIX, AZ 85012-3314 317(K)(2) OF PHSA 42USC 247B(K)(2)
602-506-1829
14. Federal Award Project Title
2. Congressional District of Recipient COVID-19 Health Improvement Plan for Maricopa County
09
3. Payment System Identifier (ID)
1866000472B9 15. Assistance Listing Number
4. Employer Identification Number (EIN) 93.391
866000472 16. Assistance Listing Program Title
5. Data Universal Numbering System (DUNS) Activities to Support State, Tribal, Local and Territorial (STLT) Health Department Response to Public
602062515 Health or Healthcare Crises
6. Recipient’s Unique Entity Identifier 17. Award Action Type
New
7. Project Director or Principal Investigator 18. Is the Award R&D?
No
Ms. Lilliana Cardenas
Manager Summary Federal Award Financial Information
lilliana.cardenas@maricopa.gov 19. Budget Period Start Date 06/01/2021 - End Date 05/31/2023
6023197737
20. Total Amount of Federal Funds Obligated by this Action $26,562,053.00
8. Authorized Official
20a. Direct Cost Amount $25,823,552.00
Mr. Max Porter 20b. Indirect Cost Amount $738,501.00
Executive Director
maxporter@mail.maricopa.gov 21. Authorized Carryover $0.00
602-506-6614 22. Offset $0.00
23. Total Amount of Federal Funds Obligated this budget period $0.00
Fe deral Agency Information
24. Total Approved Cost Sharing or Matching, where applicable $0.00
CDC Office of Financial Resources
25. Total Federal and Non-Federal Approved this Budget Period $26,562,053.00
9. Awarding Agency Contact Information
26. Project Period Start Date 06/01/2021 - End Date 05/31/2023
Jami Edwards
Grants Management Specialist 27. Total Amount of the Federal Award including Approved
qkl2@cdc.gov Cost Sharing or Matching this Project Period Not Available
4044982058
28. Authorized Treatment of Program Income
10.Program Official Contact Information ADDITIONAL COSTS
Ms. Christine Graaf 29. Grants Management Officer – Signature
khx2@cdc.gov Ms. Shirley K Byrd
404-498-0442 Grants Management Officer
30. Remarks
Page 1

DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Award
Centers for Disease Control and Prevention Award# 1 NH75OT000011-01-00
FAIN# NH75OT000011
Federal Award Date: 05/26/2021
Recipient Information 33. Approved Budget
(Excludes Direct Assistance)
Recipient Name I. Financial Assistance from the Federal Awarding Agency Only
II. Total project costs including grant funds and all other financial participation
MARICOPA, COUNTY OF
4041 N Central Ave Ste 1400 a. Salaries and Wages $5,566,834.00
Community Health Services b. Fringe Benefits $1,592,498.00
PHOENIX, AZ 85012-3314 c. Total Personnel Costs $7,159,332.00
602-506-1829
Congressional District of Recipient d. Equipment $0.00
09 e. Supplies $180,248.00
Payment Account Number and Type f. Travel $45,426.00
Employer 1866000472B9 Identification Number (EIN) Data g. Construction $0.00
866000472 h. Other $1,676,231.00
Universal Numbering System (DUNS) i. Contractual $16,762,315.00
602062515
Recipient’s Unique Entity Identifier j. TOTAL DIRECT COSTS $25,823,552.00 $25,823,552.00
Not Available
k. INDIRECT COSTS $738,501.00 $738,501.00
31. Assistance Type l. TOTAL APPROVED BUDGET $26,562,053.00 $26,562,053.00
Project Grant
m. Federal Share $26,562,053.00 $26,562,053.00
32. Type of Award
Other n. Non-Federal Share $0.00 $0.00
34. Accounting Classification Codes
FY-ACCOUNT NO. DOCUMENT NO. ADMINISTRATIVE CODE OBJECT CLASS AMT ACTION FINANCIAL ASSISTANCE APPROPRIATION
1-9390H06 21NH75OT000011C5 OT 41.51 $26,562,053.00 75-2122-0140
Page 2

DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Award
Award# 1 NH75OT000011-01-00
Centers for Disease Control and Prevention
FAIN# NH75OT000011
Federal Award Date: 05/26/2021
Direct Assistance
BUDGET CATEGORIES PREVIOUS AMOUNT (A) AMOUNT THIS ACTION (B) TOTAL (A + B)
Personnel $0.00 $0.00 $0.00
Fringe Benefits $0.00 $0.00 $0.00
Travel $0.00 $0.00 $0.00
Equipment $0.00 $0.00 $0.00
Supplies $0.00 $0.00 $0.00
Contractual $0.00 $0.00 $0.00
Construction $0.00 $0.00 $0.00
Other $0.00 $0.00 $0.00
Total $0.00 $0.00 $0.00
Page 3

AWARD ATTACHMENTS
MARICOPA, COUNTY OF 1 NH75OT000011-01-00
1. OT21-2103 Terms and Conditions

Recipient: Maricopa County Department of Public Health
AWARD INFORMATION
Incorporation: In addition to the federal laws, regulations, policies, and CDC General Terms
and Conditions for Non-research awards at
https://www.cdc.gov/grants/federalregulationspolicies/index.html, the Centers for Disease
Control and Prevention (CDC) hereby incorporates Notice of Funding Opportunity (NOFO)
number CDC-RFA-OT21-2103, entitled National Initiative to Address COVID-19 Health
Disparities Among Populations at High-Risk and Underserved, Including Racial and Ethnic
Minority Populations and Rural Communities, and application dated April 30, 2021, as may be
amended, which are hereby made a part of this Non-research award, hereinafter referred to as
the Notice of Award (NoA).
Approved Funding: Funding in the amount of $26,562,053 is approved for a two year
performance and budget period, which is June 1, 2021 through May 31, 2023. All future funding
will be based on satisfactory programmatic progress and the availability of funds.
The federal award amount is subject to adjustment based on total allowable costs incurred
and/or the value of any third party in-kind contribution when applicable.
Note: Refer to the Payment Information section for Payment Management System (PMS)
subaccount information.
Coronavirus Disease 2019 (COVID-19) Funds: A recipient of a grant or cooperative
agreement awarded by the Department of Health and Human Services (HHS) with funds made
available under the Coronavirus Preparedness and Response Supplemental Appropriations Act,
2020 (P.L. 116-123); the Coronavirus Aid, Relief, and Economic Security Act, 2020 (the
“CARES Act”) (P.L. 116-136); the Paycheck Protection Program and Health Care Enhancement
Act (P.L. 116-139); the Consolidated Appropriations Act and the Coronavirus Response and
Relief Supplement Appropriations Act, 2021 (P.L. 116-260) and/or the American Rescue Plan of
2021 [P.L. 117-2] agrees, as applicable to the award, to: 1) comply with existing and/or future
directives and guidance from the Secretary regarding control of the spread of COVID-19; 2) in
consultation and coordination with HHS, provide, commensurate with the condition of the
individual, COVID-19 patient care regardless of the individual’s home jurisdiction and/or
appropriate public health measures (e.g., social distancing, home isolation); and 3) assist the
United States Government in the implementation and enforcement of federal orders related to
quarantine and isolation.
In addition, to the extent applicable, Recipient will comply with Section 18115 of the CARES Act,
with respect to the reporting to the HHS Secretary of results of tests intended to detect SARS–
CoV–2 or to diagnose a possible case of COVID–19. Such reporting shall be in accordance with
guidance and direction from HHS and/or CDC. HHS laboratory reporting guidance is posted at:
https://www.hhs.gov/sites/default/files/covid-19-laboratory-data-reporting-guidance.pdf.
Further, consistent with the full scope of applicable grant regulations (45 C.F.R. 75.322), the
purpose of this award, and the underlying funding, the recipient is expected to provide to CDC
copies of and/or access to COVID-19 data collected with these funds, including but not limited
to data related to COVID-19 testing. CDC will specify in further guidance and directives what is
encompassed by this requirement.

This award is contingent upon agreement by the recipient to comply with existing and future
guidance from the HHS Secretary regarding control of the spread of COVID-19. In addition,
recipient is expected to flow down these terms to any subaward, to the extent applicable to
activities set out in such subaward.
Pre-Award Costs: Pre-award costs dating back to March 15, 2021 – and directly related to the
COVID-19 outbreak response are allowable.
FUNDING RESTRICTIONS AND LIMITATIONS
Indirect Costs:
The recipient’s indirect costs are approved and based on a de minimis rate of ten (10) percent
of modified total direct costs (MTDC) as defined in 45 CFR Part 75.2, effective May 21, 2021.
REPORTING REQUIREMENTS
Required Disclosures for Federal Awardee Performance and Integrity Information System
(FAPIIS): Consistent with 45 CFR 75.113, applicants and recipients must disclose in a timely
manner, in writing to the CDC, with a copy to the HHS Office of Inspector General (OIG), all
information related to violations of federal criminal law involving fraud, bribery, or gratuity
violations potentially affecting the federal award. Subrecipients must disclose, in a timely
manner in writing to the prime recipient (pass through entity) and the HHS OIG, all information
related to violations of federal criminal law involving fraud, bribery, or gratuity violations
potentially affecting the federal award. Disclosures must be sent in writing to the CDC and to
the HHS OIG at the following addresses:
CDC, Office of Grants Services
John McGee, Grants Management Specialist
Centers for Disease Control and Prevention
Global Health Services Branch
2939 Flowers Road
Atlanta, GA 30341
Email: qsj4@cdc.gov (Include “Mandatory Grant Disclosures” in subject line)
AND
U.S. Department of Health and Human Services
Office of the Inspector General
ATTN: Mandatory Grant Disclosures, Intake Coordinator
330 Independence Avenue, SW
Cohen Building, Room 5527
Washington, DC 20201
Fax: (202)-205-0604 (Include “Mandatory Grant Disclosures” in subject line) or
Email: MandatoryGranteeDisclosures@oig.hhs.gov

Recipients must include this mandatory disclosure requirement in all subawards and
contracts under this award.
Failure to make required disclosures can result in any of the remedies described in 45 CFR
75.371. Remedies for noncompliance, including suspension or debarment (See 2 CFR
parts 180 and 376, and 31 U.S.C. 3321).
CDC is required to report any termination of a federal award prior to the end of the period of
performance due to material failure to comply with the terms and conditions of this award in
the OMB-designated integrity and performance system accessible through SAM (currently
FAPIIS). (45 CFR 75.372(b)) CDC must also notify the recipient if the federal award is
terminated for failure to comply with the federal statutes, regulations, or terms and conditions
of the federal award. (45 CFR 75.373(b))
PAYMENT INFORMATION
The HHS Office of the Inspector General (OIG) maintains a toll-free number (1-800-HHS-TIPS
[1- 800-447-8477]) for receiving information concerning fraud, waste, or abuse under grants and
cooperative agreements. Information also may be submitted by e-mail to hhstips@oig.hhs.gov
or by mail to Office of the Inspector General, Department of Health and Human Services, Attn:
HOTLINE, 330 Independence Ave., SW, Washington DC 20201. Such reports are treated as
sensitive material and submitters may decline to give their names if they choose to remain
anonymous.
Payment Management System Subaccount: Funds awarded in support of approved
activities have been obligated in a subaccount in the PMS, herein identified as the “P
Account”. Funds must be used in support of approved activities in the NOFO and the
approved application.
The grant document number identified on the bottom of Page 1 of the Notice of Award must
be known in order to draw down funds.
PROGRAM OR FUNDING SPECIFIC CLOSEOUT REQUIREMENTS
The final programmatic report format required is the following.
Final Performance Progress and Evaluation Report: This report should include the
information specified in the NOFO and is submitted 90 days following the end of the period
of performance via www.grantsolutions.gov . At a minimum, the report will include the
following:
• Statement of progress made toward the achievement of originally stated aims.
• Description of results (positive or negative) considered significant.
• List of publications resulting from the project, with plans, if any, for further publication.
Additional guidance may be provided by the GMS and found at:
https://www.cdc.gov/grants/alreadyhavegrant/Reporting.html

CDC Staff Contacts
Grants Management Specialist: The GMS is the federal staff member responsible for the day-
to-day management of grants and cooperative agreements. The GMS is the primary contact of
recipients for business and administrative matters pertinent to grant awards.
Program/Project Officer: The PO is the federal official responsible for monitoring the
programmatic, scientific, and/or technical aspects of grants and cooperative agreements, as
well as contributing to the effort of the award under cooperative agreements.
Grants Management Officer: The GMO is the federal official responsible for the business and
other non-programmatic aspects of grant awards. The GMO is the only official authorized to
obligate federal funds and is responsible for signing the NoA, including revisions to the NoA that
change the terms and conditions. The GMO serves as the counterpart to the business officer of
the recipient organization.